- Lymphoproliferation disease in HIV positive patients2020 | First Faculty of Medicine
- Place of radiotherapy in the malignant lymphoma treatment2020 | Faculty of Medicine in Hradec Králové
- Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases2016 | Second Faculty of Medicine
- Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma2023 | Second Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Burkitt lymphoma in pregnancy - Case report2010 | Publication without faculty affiliation
- Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: Results based on the NHL BFM 90 protocols1999 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT2021 | First Faculty of Medicine
- Current diagnostic and therapeutic guidelines for lymphoma. III2009 | Publication without faculty affiliation
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study2023 | First Faculty of Medicine
- Extranodal diffuse large B-cell lymphoma in the orofacial region (5 case reports)Publication without faculty affiliation
- Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders2008 | Second Faculty of Medicine
- Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study2015 | Faculty of Medicine in Hradec Králové
- Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study2016 | Publication without faculty affiliation
- Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using (18)F-FDG-PET/CT2011 | First Faculty of Medicine
- In Vivo Modulation of Angiogenic Gene Expression by Acyclic Nucleoside Phosphonates PMEDAP and PMEG2009 | First Faculty of Medicine
- Single nucleotide polymorphism in 5'-flanking region of BCL6 is not associated with increased risk of non-Hodgkin's lymphoma2006 | First Faculty of Medicine
- Single nucleotide polymorphism in 5'-flanking region of BCL6 is not associated with increased risk of non-Hodgkin's lymphoma2006 | Faculty of Physical Education and Sport
- The History, Toxicity and Adverse Human Health and Environmental Effects Related to the Use of Agent Orange2013 | First Faculty of Medicine
- Diagnostic procedure in patients with neoplasm and malignant pleural effusion: Our experience2012 | Third Faculty of Medicine
- The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients2019 | Second Faculty of Medicine
- Malignant lymphomas2007 | Second Faculty of Medicine